• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 AXIUM PGLA HLX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 AXIUM PGLA HLX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number PC-3-8-HELIX
Medical Device Problem Codes Break (1069); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/09/2022
Type of Reportable Event Malfunction
Event or Problem Description
Medtronic received information regarding two axium coils of the same model and lot that had resistance in the sheath and at the catheter hub.It was reported that significant resistance was felt as the distal tip of the coil left the coiling sheath and began entering into the catheter hub.The surgeon felt the non-tapered distal segment of the coil sheath and gap between the non-tapered sheath and the hub of the non-medtronic balloon catheter "may cause the axium coil to break prematurely at the gap causing heavy resistance to occur." the coil was replaced by another manufacturer's product to complete the procedure.The event was not associated with a patient.Concomitant device: microvention sceptor c balloon additional information received reported that there was no malformation or defect noted in the coiling sheath.The doctor stated that as the non-tapered coiling sheath of micrfx coil enters the hub a gap can occur which causes the coil the break and thus leads to the heavy resistance.
 
Additional Manufacturer Narrative
See manufacturer report # 2029214-2022-00994 for the other coil involved in this event.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information received reported that both coils encountered heavy resistance at the gap between non taped coiling sheath and microcatheter hub.The break was located at the gap between non tapered coiling sheath entering hub of the microcatheter.No other damages were noted by the physician in regards to the coils.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM PGLA HLX
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key14681467
Report Number2029214-2022-00995
Device Sequence Number4712368
Product Code KRD
UDI-Device Identifier00847536033016
UDI-Public00847536033016
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K081465
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/14/2024
Device Model NumberPC-3-8-HELIX
Device Catalogue NumberPC-3-8-HELIX
Device Lot NumberB298932
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/18/2022
Supplement Date Received by Manufacturer06/15/2022
Initial Report FDA Received Date06/13/2022
Supplement Report FDA Received Date07/12/2022
Date Device Manufactured11/15/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-